We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 2,643 results
  1. Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7

    Objective

    Long QT syndrome type 7 (Andersen–Tawil syndrome, ATS), which is caused by KCNJ2 gene mutation, often leads to ventricular arrhythmia,...

    Peipei Chen, Junyu Long, ... Shuyang Zhang in Journal of Translational Medicine
    Article Open access 25 March 2024
  2. Obesity Potentiates the Risk of Drug-Induced Long QT Syndrome - Preliminary Evidence from WNIN/Ob Spontaneously Obese Rat

    Drug-induced long QT syndrome (DI-LQTS) is fatal and known to have a higher incidence in women rather than in men. Multiple risk factors potentiate...

    Ajay Godwin Potnuri, Kallamadi Prathap Reddy, ... Nemani Harishankar in Cardiovascular Toxicology
    Article 24 July 2021
  3. Status of Safety Pharmacology and Present Guidelines

    This chapter describes the development from General Pharmacology to Safety Pharmacology. The development of the different ICH guidelines is discussed...
    Living reference work entry 2024
  4. Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus

    Purpose

    Imeglimin is the first in a new class of oral antidiabetic agents, the glimins, currently in development to improve glycemic control in...

    Julie Dubourg, Sandrine Perrimond-Dauchy, ... Pascale Fouqueray in European Journal of Clinical Pharmacology
    Article 18 June 2020
  5. Plasma potassium concentration and cardiac repolarisation markers, Tpeak–Tend and Tpeak–Tend/QT, during and after exercise in healthy participants and in end-stage renal disease

    Purpose

    The cardiac T-wave peak-to-end interval (T pe ) is thought to reflect dispersion in ventricular repolarisation, with abnormalities in T pe ...

    Cao Thach Tran, Tania Atanasovska, ... Michael J. McKenna in European Journal of Applied Physiology
    Article 20 January 2022
  6. Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients

    Objective

    The purpose of this study was to analyze the occurrence characteristics, clinical manifestations, medication distribution, and incidence of...

    Haili Guo, Peng Li, ... **gchuang Lu in European Journal of Clinical Pharmacology
    Article 11 April 2023
  7. Kv11.1 (hERG1) Channels and Cardiac Arrhythmia

    The rapid delayed rectifier K+ current (IKr) is one of several outward currents that mediate repolarization of cardiac action potentials in humans...
    Michael C. Sanguinetti in Heart Rate and Rhythm
    Chapter 2023
  8. Impact of Phase 1 study design on estimation of QT interval prolongation risk using exposure–response analysis

    The International Council for Harmonisation (ICH) guidelines have been revised allowing for modeling of concentration-QT (C-QT) data from Phase I...

    Nikolaos Tsamandouras, Sridhar Duvvuri, Steve Riley in Journal of Pharmacokinetics and Pharmacodynamics
    Article 29 October 2019
  9. QTc Prolongation in COVID-19 Patients Using Chloroquine

    Chloroquine is used in the treatment of patients with COVID-19 infection, although there is no substantial evidence for a beneficial effect....

    Matthijs L. Becker, Dominic Snijders, ... Thijs J. Giezen in Cardiovascular Toxicology
    Article 02 January 2021
  10. Association Between Vomiting and QT Hysteresis: Data from a TQT Study with the Endothelin A Receptor Antagonist Clazosentan

    This study investigated the potential QT liability of the selective endothelin-1 A receptor antagonist clazosentan at a therapeutic (20 mg/h) and...

    Pierre-Eric Juif, Jasper Dingemanse, ... Mike Ufer in The AAPS Journal
    Article 03 August 2020
  11. Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model

    Antiviral therapies for treatment of COVID-19 may be associated with significant proarrhythmic potential. In the present study, the potential...

    Julian Wolfes, Lina Kirchner, ... Gerrit Frommeyer in Cardiovascular Toxicology
    Article Open access 08 June 2024
  12. PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration

    Plasma drug concentration and electrocardiogram (ECG) data from a drug–drug interaction (DDI) study employing the metabolic inhibitor itraconazole...

    Felix Jaminion, Darren Bentley, ... Cheikh Diack in Journal of Pharmacokinetics and Pharmacodynamics
    Article 22 June 2020
  13. Population pharmacokinetic/pharmacodynamic modeling of nifekalant injection with varies dosing plan in Chinese volunteers: a randomized, blind, placebo-controlled study

    Nifekalant hydrochloride is a class III antiarrhythmic agent which could increase the duration of the action potential and the effective refractory...

    Juanjuan Jiang, Li Xu, ... Lei Tian in Journal of Pharmacokinetics and Pharmacodynamics
    Article 11 August 2023
  14. QT prolongation and vortioxetine: a post-marketing study and comparison with other serotonin reuptake inhibitors

    Constance Bordet, Vanessa Rousseau, ... Jean-Louis Montastruc in Psychopharmacology
    Article 21 January 2020
  15. Clinical utility gene card for: Long-QT syndrome

    Britt M. Beckmann, Stefanie Scheiper-Welling, ... Silke Kauferstein in European Journal of Human Genetics
    Article Open access 24 May 2021
  16. Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs

    Dose selection for investigations of intrinsic and extrinsic factors of pharmacokinetic variability as well as safety is a challenging question in...

    Rudiger Kaspera, Yoshihisa Shitara in The AAPS Journal
    Article 17 June 2024
  17. Validation of Corrected and Dispersed QT as Predictors of Adverse Outcomes in Acute Cardiotoxicities

    Acute cardiovascular poisoning is a major cause of adverse outcomes in poisoning emergencies. The prognostic validity of corrected QT (QTc) and...

    Ghada N. El-Sarnagawy, Aliaa E. Shaban, Heba I. Lashin in Cardiovascular Toxicology
    Article 05 January 2021
  18. Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts

    Recent results from data mining analyses and reports of adverse drug events suggest a QT-prolonging drug–drug interaction resulting from the...

    Julian Wolfes, Christian Ellermann, ... Gerrit Frommeyer in Cardiovascular Toxicology
    Article 04 June 2020
  19. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels

    Drinking fresh grapefruit juice is associated with a significant prolongation of the QT segment on the electrocardiogram (ECG) in healthy volunteers....

    Camille Sanson, Rachid Boukaiba, ... G. Andrees Bohme in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 12 April 2022
Did you find what you were looking for? Share feedback.